Autonomix Medical, Inc. last reported quarterly results on Feb 13, 2025, for Q3 FY2025 (the quarter ended Dec 31, 2024): revenue of $0. It usually reports 43–61 days after a quarter ends.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 43–61 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Feb 13, 2025
44 days after quarter end
|
Q3 FY2025
ended Dec 31, 2024
|
0
|
-3
+12.9%
|
—
|
|
Nov 12, 2024
43 days after quarter end
|
Q2 FY2024
ended Sep 30, 2024
|
0
|
-3
|
—
|
|
Aug 13, 2024
44 days after quarter end
|
—
ended Jun 30, 2024
|
—
|
—
|
—
|
|
May 31, 2024
61 days after quarter end
|
—
ended Mar 31, 2024
|
—
|
—
|
—
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- AMIX (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- DE
- Headquarters
- The Woodlands, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1617867
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.